Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-18-062779

Chief Executive Officer sold 90,000 shares at $14.07 ($1,266,300)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Anzalone Christopher Richard Chief Executive Officer 2018-12-12 Sale −90,000 $14.07 $1,266,300 1,632,455 D
Open-market sales · 90,000 sh · avg $14.07 · $1,266,300
Loading xslF345X03/doc4.xml…